抗菌素耐药性诊断市场规模、份额和趋势分析报告：按技术（微生物培养、免疫测定、PCR、NGS）、病原体、最终用户、地区、细分市场预测 2022-2030 年

抗菌素耐药性诊断市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球抗菌素耐药性诊断市场预计将达到 67 亿美元。 从 2022 年到 2030 年，该市场预计将以 6.2% 的复合年增长率增长。 发生耐药性感染的风险不断增加，尤其是在医疗机构中，以及政府和非政府组织为应对 AMR 威胁所做的越来越多的努力是市场增长的主要驱动力。 市场参与者为管理抗菌素耐药性而采取的各种战略举措也有助于市场扩张。 例如，2021 年 3 月，bioMerieux 和 GIZ 联手帮助尼日利亚疾病控制中心加强对抗 AMR 的斗争。

由于对耐药感染的快速检测和 PoC 检测越来越多地被采用，预计该市场在预测期内将会扩大。 此外，丹纳赫和雅培等主要市场参与者拥有强大的抗菌素耐药性感染快速诊断检测产品组合。 此外，AMR 行业联盟等非政府组织越来越多地参与协助监管机构制定战略，以支持开发管理抗菌素耐药性的诊断解决方案。

用于开髮用于诊断抗菌素耐药性感染的新型自动化检测解决方案的资金不断增加，预计将在预测期内推动市场增长。 例如，2022 年 5 月，欧洲投资银行授予 POCARED Diagnostics 超过 2400 万美元，用于研究和开发针对微生物疾病的全自动测试。 POCARED Diagnostics 参与开发可在数小时内提供结果的新型微生物测试。

预计未来几年抗菌素耐药性会增加。 因此，为了有效管理和监测抗菌素耐药性的进展，对准确和快速检测选项的需求预计会增加。 根据疾病预防控制中心的数据，在美国，由于抗菌素耐药性导致的年度直接医疗费用约为 200 亿美元。

主要市场参与者不断致力于开发新的测试以巩固其市场地位。 此外，主要参与者还采用其他战略，如收购、合作伙伴关係和合作，以扩大其在世界不同地区的产品组合。 例如，2022 年 8 月，Accelerate Diagnostics 和 BD 宣布合作应对抗菌素耐药性的威胁。 通过该协议，BD 将向其庞大的客户群提供 Accelerate Diagnostics 针对抗生素相关耐药性的快速诊断解决方案。

抗微生物药物耐药性诊断市场报告要点

2021年技术领域，PCR凭藉其高渗透率和技术进步占据最大份额

按病原体划分，2021年MRSA感染高发、产品上市激增，耐甲氧西林金黄色葡萄球菌占比最大

在最终用户中，由于患者住院率高和细菌感染率高，2021 年医院板块的销售额贡献最大

由于市场参与者增加投资和增加研究活动，预计亚太地区在预测期内将呈现最快的增长

内容

第1章调查方法及范围

• 市场细分和范围
  • 细分范围
  • 区域范围
• 调查方法
• 信息采购
  • 购买的数据库：
  • GVR 内部数据库
  • 次要信息
  • 初步调查
  • 初步调查的内容
• 信息或数据分析
  • 数据分析模型
• 市场製定和验证
• 模型详细信息
  • 商品流分析
    • 方法：产品流方法
• 调查假设
• 二级信息列表
• 缩写列表
• 目的

第 2 章执行摘要

• 市场展望
• 竞争考虑

第 3 章抗菌素耐药性诊断市场：变量、趋势和范围

• 市场系列展望
  • 母公司市场
• 市场动态
  • 市场驱动因素分析
    • 发生耐药性感染的风险增加
    • 介绍用于诊断 AMR 感染的新技术
    • 有利的政府举措
  • 市场製约因素分析
    • 存在关于诊断的严格规则和规定
• 描绘渗透率和增长前景
• 抗菌素耐药性诊断：市场分析工具
  • 行业分析 - 搬运工
  • PESTLE 分析
• 监管框架
• 价格分析

第 4 章抗菌素耐药性诊断市场：按技术细分分析，2018-2030

• 定义和范围
• 2021 年和 2030 年技术市场份额分析
• 部门仪表板
• 全球抗菌素耐药性诊断市场，按技术划分，2018-2030 年
• 2018-2030 年市场规模和预测、趋势分析
  • 微生物培养
  • 免疫测定
  • 聚合□链反应
  • 下一代测序
  • 质谱
  • 快速和护理点
  • 其他

第 5 章抗菌素耐药性诊断市场：细分分析，按病原体，2018-2030

• 定义和范围
• 2021 年和 2030 年病原体市场份额分析
• 部门仪表板
• 全球抗菌素耐药性诊断市场，按病原体，2018-2030 年
• 2018-2030 年市场规模和预测、趋势分析
  • 耐药性肺炎链球菌 (DRSP)
  • 耐药弯曲桿菌 (DRC)
  • 艰难梭菌 (CD)
  • 耐甲氧西林金黄色葡萄球菌 (MRSA)
  • 抗药性淋病奈瑟菌 (DRNG)
  • 耐药沙门氏菌 (DRNTS)
  • 其他

第 6 章抗菌素耐药性诊断市场：细分分析，按最终用户分类，2018-2030

• 定义和范围
• 2021 年和 2030 年最终用户市场份额分析
• 部门仪表板
• 全球抗菌素耐药性诊断市场，按最终用户划分，2018-2030 年
• 2018-2030 年市场规模和预测、趋势分析
  • 医院
  • 诊断实验室
  • 製药和生物技术公司
  • 其他

第 7 章抗菌素耐药性诊断市场：按地区划分的细分分析，2018-2030

• 定义和范围
• 2021 年和 2030 年区域市场份额分析
• 区域市场仪表板
• 区域市场概况
• SWOT 分析
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 2018-2030 年市场规模、预测、收入和趋势分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 8 章抗菌素耐药性诊断市场：竞争分析

• 主要市场进入者的近期趋势和影响分析
  • 安索夫矩阵
  • 热图分析
  • 主要交易和战略联盟分析
    • 合资企业
    • 许可协议
    • 产品发布
    • 会议和活动
• 公司分类
  • 创新者
  • 市场领导者
• 供应商情况
  • 主要分销商和渠道合作伙伴列表
  • 主要客户
• 上市公司
  • 竞争仪表板分析
    • 市场差异化因素
• 私人公司
  • 主要初创公司名单
• 公司简介
  • 生物梅里埃
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 雅培
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 商务部
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 丹纳赫
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Accelerate Diagnostics, Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 摩尔斯德
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 维拉诊断
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 维斯比医疗公司
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Hologic, Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措

Antimicrobial Resistance Diagnostics Market Growth & Trends:

The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies' efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Antimicrobial Resistance Diagnostics Market Report Highlights:

• PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements

• Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches

• In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections

• In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Competitive Insights

Chapter 3 Antimicrobial Resistance Diagnostics Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increase in risk of developing drug - resistant bacterial infections
    • 3.2.1.2 Introduction of novel technologies to diagnose AMR infections
    • 3.2.1.3 Favorable government initiatives
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 Presence of stringent rules and regulations pertaining to diagnostics
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Antimicrobial Resistance Diagnostics: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework
• 3.6 Pricing Analysis

Chapter 4 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Technology, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Technology Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Antimicrobial Resistance Diagnostics Market, by Technology, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Microbiology Culture
    • 4.5.1.1 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2 Immunoassay
    • 4.5.2.1 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.3 PCR
    • 4.5.3.1 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.4 NGS
    • 4.5.4.1 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.5 Mass Spectrometry
    • 4.5.5.1 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.6 Rapid & Point of Care
    • 4.5.6.1 Rapid & Point of Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.7 Others
    • 4.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Pathogen 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Pathogen Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Antimicrobial Resistance Diagnostics Market, by Pathogen, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Drug Resistant Streptococcus Pneumoniae (DRSP)
    • 5.5.1.1 Drug resistant streptococcus pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2 Drug Resistant Campylobacter (DRC)
    • 5.5.2.1 Drug resistant campylobacter (DRC) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.3 Clostridium Difficile (CD)
    • 5.5.3.1 Clostridium difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.4 Methicillin Resistant Staphylococcus Aureus (MRSA)
    • 5.5.4.1 Methicillin resistant staphylococcus aureus (MRSA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.5 Drug Resistant Neisseria Gonorrhoeae (DRNG)
    • 5.5.5.1 Drug resistant neisseria gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.6 Drug Resistant Salmonella (DRNTS)
    • 5.5.6.1 Drug resistant salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.7 Others
    • 5.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Antimicrobial Resistance Diagnostics Market Segment Analysis, By End User, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 End User Market Share Analysis, 2021 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Antimicrobial Resistance Diagnostics Market, by End User, 2018 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.5.1 Hospitals
    • 6.5.1.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2 Diagnostic Laboratories
    • 6.5.2.1 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3 Pharmaceutical & Biotechnology Companies
    • 6.5.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4 Others
    • 6.5.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2021 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 SWOT Analysis
  • 7.5.1 North America
  • 7.5.2 Europe
  • 7.5.3 Asia Pacific
  • 7.5.4 Latin America
  • 7.5.5 Middle East and Africa
• 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
  • 7.6.1 North America
    • 7.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.2 U.S.
    • 7.6.1.2.1 U.S. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.1.3 Canada
    • 7.6.1.3.1 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2 Europe
    • 7.6.2.1 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.2 U.K.
    • 7.6.2.2.1 U.K. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.3 Germany
    • 7.6.2.3.1 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.4 Spain
    • 7.6.2.4.1 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.5 France
    • 7.6.2.5.1 France antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.6 Italy
    • 7.6.2.6.1 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3 Asia Pacific
    • 7.6.3.1 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.2 Japan
    • 7.6.3.2.1 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.3 China
    • 7.6.3.3.1 China antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.4 India
    • 7.6.3.4.1 India antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.5 South Korea
    • 7.6.3.5.1 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.6 Australia
    • 7.6.3.6.1 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4 Latin America
    • 7.6.4.1 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.2 Brazil
    • 7.6.4.2.1 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.3 Mexico
    • 7.6.4.3.1 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.4 Argentina
    • 7.6.4.4.1 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5 MEA
    • 7.6.5.1 MEA antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.2 South Africa
    • 7.6.5.2.1 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.3 Saudi Arabia
    • 7.6.5.3.1 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.4 UAE
    • 7.6.5.4.1 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Antimicrobial Resistance Diagnostics Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.1.1 Ansoff matrix
  • 8.1.2 Heat map analysis
  • 8.1.3 Major Deals and Strategic Alliances Analysis
    • 8.1.3.1 Joint Ventures
    • 8.1.3.2 Licensing Agreements
    • 8.1.3.3 Product Launches
    • 8.1.3.4 Conferences and Campaigns
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List of key distributors and channel partners
  • 8.3.2 Key customers
• 8.4 Public Companies
  • 8.4.1 Competitive Dashboard Analysis
    • 8.4.1.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List of key emerging companies
• 8.6 Company Profiles
  • 8.6.1 bioMerieux
    • 8.6.1.1 Company overview
    • 8.6.1.2 Financial performance
    • 8.6.1.3 Product benchmarking
    • 8.6.1.4 Strategic initiatives
  • 8.6.2 F. Hoffmann - La Roche Ltd
    • 8.6.2.1 Company overview
    • 8.6.2.2 Financial performance
    • 8.6.2.3 Product benchmarking
    • 8.6.2.4 Strategic initiatives
  • 8.6.3 Abbott
    • 8.6.3.1 Company overview
    • 8.6.3.2 Financial performance
    • 8.6.3.3 Product benchmarking
    • 8.6.3.4 Strategic initiatives
  • 8.6.4 BD
    • 8.6.4.1 Company overview
    • 8.6.4.2 Financial performance
    • 8.6.4.3 Product benchmarking
    • 8.6.4.4 Strategic initiatives
  • 8.6.5 Danaher
    • 8.6.5.1 Company overview
    • 8.6.5.2 Financial performance
    • 8.6.5.3 Product benchmarking
    • 8.6.5.4 Strategic initiatives
  • 8.6.6 Accelerate Diagnostics, Inc.
    • 8.6.6.1 Company overview
    • 8.6.6.2 Financial performance
    • 8.6.6.3 Product benchmarking
    • 8.6.6.4 Strategic initiatives
  • 8.6.7 Molsid
    • 8.6.7.1 Company overview
    • 8.6.7.2 Financial performance
    • 8.6.7.3 Product benchmarking
    • 8.6.7.4 Strategic initiatives
  • 8.6.8 Vela Diagnostics
    • 8.6.8.1 Company overview
    • 8.6.8.2 Financial performance
    • 8.6.8.3 Product benchmarking
    • 8.6.8.4 Strategic initiatives
  • 8.6.9 Visby Medical, Inc.
    • 8.6.9.1 Company overview
    • 8.6.9.2 Financial performance
    • 8.6.9.3 Product benchmarking
    • 8.6.9.4 Strategic initiatives
  • 8.6.10 Hologic, Inc.
    • 8.6.10.1 Company overview
    • 8.6.10.2 Financial performance
    • 8.6.10.3 Product benchmarking
    • 8.6.10.4 Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Leading market players anticipated to witness highest growth
• Table 4 Global Antimicrobial Resistance Diagnostics Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 6 Global Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 7 Global Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 8 North America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 10 North America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 11 North America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 12 U.S. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 13 U.S. Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 14 U.S. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 15 Canada Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 16 Canada Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 17 Canada Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 18 Europe Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 19 Europe Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 20 Europe Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 21 Europe Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 22 Germany Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 23 Germany Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 24 Germany Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 25 France Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 26 France Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 27 France Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 28 U.K. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 29 U.K. Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 30 U.K. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 31 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 32 Spain Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 33 Spain Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 34 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 35 Italy Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 36 Italy Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 37 Italy Antimicrobial Resistance Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 38 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 39 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 42 Japan Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 43 Japan Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 44 Japan Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 45 China Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 46 China Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 47 China Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 48 India Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 49 India Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 50 India Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 51 Australia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 52 Australia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 53 Australia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 54 South Korea Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 55 South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 56 South Korea Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 57 Latin America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 58 Latin America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 59 Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 60 Latin America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 61 Brazil Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 62 Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 63 Brazil Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 64 Mexico Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 65 Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 66 Mexico Antimicrobial Resistance Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 67 Argentina Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 68 Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 69 Argentina Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 70 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 71 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 72 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 73 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)
• Table 74 South Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 75 South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 76 South Africa Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 77 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 80 UAE Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 81 UAE Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 82 UAE Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Antimicrobial resistance diagnostics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2020)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Antimicrobial resistance diagnostics market: technology movement analysis
• Fig. 17 Antimicrobial resistance diagnostics market: technology segment dashboard
• Fig. 18 Antimicrobial resistance diagnostics market technology outlook: Key takeaways
• Fig. 19 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Rapid & point of care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Antimicrobial resistance diagnostics market: pathogen analysis
• Fig. 27 Antimicrobial resistance diagnostics market: pathogen segment dashboard
• Fig. 28 Antimicrobial resistance diagnostics market pathogen outlook: Key takeaways
• Fig. 29 Drug Resistant Streptococcus Pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Drug Resistant Campylobacter (DRC)market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Clostridium Difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Methicillin Resistant Staphylococcus Aureus (MRSA)market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Drug Resistant Neisseria Gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Drug Resistant Salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Antimicrobial resistance diagnostics market: end user movement analysis
• Fig. 37 Antimicrobial resistance diagnostics market: end user segment dashboard
• Fig. 38 Antimicrobial resistance diagnostics market, end user outlook: Key takeaways
• Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Regional outlook estimates and forecasts, 2021 & 2030
• Fig. 44 Regional market dashboard
• Fig. 45 Regional market place: Key takeaways
• Fig. 46 North America, SWOT
• Fig. 47 Europe, SWOT
• Fig. 48 Asia Pacific, SWOT
• Fig. 49 Latin America, SWOT
• Fig. 50 Middle East and Africa, SWOT
• Fig. 51 North America
• Fig. 52 North America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 53 U.S.
• Fig. 54 U.S. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 55 Canada
• Fig. 56 Canada antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 57 Europe
• Fig. 58 Europe antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 59 U.K.
• Fig. 60 U.K. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 61 Germany
• Fig. 62 Germany antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 63 Spain
• Fig. 64 Spain antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 65 France
• Fig. 66 France antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 67 Italy
• Fig. 68 Italy antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific
• Fig. 70 Asia Pacific antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 71 Japan
• Fig. 72 Japan antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 73 China
• Fig. 74 China antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 75 India
• Fig. 76 India antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 77 South Korea
• Fig. 78 South Korea antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 79 Australia
• Fig. 80 Australia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 81 Latin America
• Fig. 82 Latin America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 83 Brazil
• Fig. 84 Brazil antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 85 Mexico
• Fig. 86 Mexico antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 87 Argentina
• Fig. 88 Argentina antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 89 Middle East and Africa
• Fig. 90 MEA antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 91 South Africa
• Fig. 92 South Africa antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 93 Saudi Arabia
• Fig. 94 Saudi Arabia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 95 UAE
• Fig. 96 UAE antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 97 Ansoff Matrix
• Fig. 98 Heat map analysis
• Fig. 99 Market differentiators